Matches in Wikidata for { <http://www.wikidata.org/entity/Q91654980> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q91654980 description "article scientifique publié en 2018" @default.
- Q91654980 description "artículu científicu espublizáu n'ochobre de 2018" @default.
- Q91654980 description "im Oktober 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91654980 description "scientific article published on 26 October 2018" @default.
- Q91654980 description "wetenschappelijk artikel" @default.
- Q91654980 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q91654980 name "Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-" @default.
- Q91654980 name "Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-" @default.
- Q91654980 type Item @default.
- Q91654980 label "Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-" @default.
- Q91654980 label "Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-" @default.
- Q91654980 prefLabel "Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-" @default.
- Q91654980 prefLabel "Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-" @default.
- Q91654980 P1433 Q91654980-0256AB5C-F2B9-45D3-BDF9-FD2732710E57 @default.
- Q91654980 P1476 Q91654980-A9EDA73A-3A6D-4DE1-B6B3-98BD65C33A3B @default.
- Q91654980 P2093 Q91654980-0F069B7B-A312-4204-A24D-EE921D82B71A @default.
- Q91654980 P2093 Q91654980-3F7E60AA-7C69-43F4-A0AD-F253EB05CA1F @default.
- Q91654980 P304 Q91654980-C78F24FC-6499-4C04-8DE3-99ECB8307398 @default.
- Q91654980 P31 Q91654980-355F32F3-C598-4EBA-B721-5F906E66D99C @default.
- Q91654980 P356 Q91654980-F1E1FFEF-FC4A-4DE7-93C9-2E942F2A1CA7 @default.
- Q91654980 P433 Q91654980-8AA2E365-5F86-49FC-A21C-0BCB5D37CFA8 @default.
- Q91654980 P478 Q91654980-662943B3-E670-427C-BECB-C645D82D9731 @default.
- Q91654980 P577 Q91654980-920CF1FF-934A-437B-83EC-6C27F3B51EB2 @default.
- Q91654980 P698 Q91654980-F09DEFA6-E00F-47B8-AB58-605F8196DDF7 @default.
- Q91654980 P921 Q91654980-A387934B-A319-482E-849B-E64D49A06E23 @default.
- Q91654980 P921 Q91654980-C712AEB8-46F9-43F5-BFF8-BC05F8BE208B @default.
- Q91654980 P356 J.EURURO.2018.10.029 @default.
- Q91654980 P698 30773206 @default.
- Q91654980 P1433 Q15763991 @default.
- Q91654980 P1476 "Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-31" @default.
- Q91654980 P2093 "Abdenour Nabid" @default.
- Q91654980 P2093 "Luis Souhami" @default.
- Q91654980 P304 "e63" @default.
- Q91654980 P31 Q13442814 @default.
- Q91654980 P356 "10.1016/J.EURURO.2018.10.029" @default.
- Q91654980 P433 "3" @default.
- Q91654980 P478 "75" @default.
- Q91654980 P577 "2018-10-26T00:00:00Z" @default.
- Q91654980 P698 "30773206" @default.
- Q91654980 P921 Q1640214 @default.
- Q91654980 P921 Q42824827 @default.